Cardioprotection with volatile anesthetics: Mechanisms and clinical implications

Anesthesia and Analgesia

Volumn 100, Issue 6, 2005, Pages 1584-1593

  De Hert, Stefan G ^a   Turani, Franco ^b   Mathur, Sanjiv ^c   Stowe, David F ^d,e  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SUDBURY REGIONAL HOSPITAL   (Canada)

^d MARQUETTE UNIVERSITY   (United States)

^e CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; CYTOCHROME C OXIDASE; DESFLURANE; ENFLURANE; HALOTHANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INHALATION ANESTHETIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; ISOFLURANE; MIDAZOLAM; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPOFOL; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SEVOFLURANE; SUFENTANIL; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG INHIBITION; DRUG MECHANISM; ELECTRON TRANSPORT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; MITOCHONDRIAL RESPIRATION; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SURGICAL MORTALITY; SURGICAL RISK;

ANESTHETICS, INHALATION; CLINICAL TRIALS; HEART DISEASES; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL REPERFUSION INJURY; POSTOPERATIVE COMPLICATIONS;

EID: 19044365674     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000153483.61170.0C     Document Type: Review

References (93)

1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
2. Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 2000;92:253-9.
3. Kloner R, Jennings R. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications Part 1. Circulation 2001;104:2981-9.
4. Kloner R, Jennings R. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications Part 2. Circulation 2001;104:3158-67.
5. Gross GJ, Kersten JR, Warltier DC. Mechanisms of postischemic contractile dysfunction. Ann Thorac Surg 1999;68:1898-904.
6. Piper HM, Meuter K, Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 2003;75:S644-8.
7. Heusch G, Schulz R. The biology of myocardial hibernation. Trends Cardiovasc Med 2000;10:108-14.
8. Lesnefsky EJ, Moghaddas S, Tandler B, et al. Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure. J Mol Cell Cardiol 2001;33:1065-89.
9. Ross S, Foex P. Protective effects of anaesthetics in reversible and irreversible ischaemia-reperfusion injury. Br J Anaesth 1999;82:622-32.
10. Stowe DF, Kevin LG. Cardiac preconditioning by volatile anesthetic agents: a defining role for altered mitochondrial bioenergetics. Antioxid Redox Signal 2004;6:439-48.
11. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
12. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991;260:H796-804.
13. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293-9.
14. Gross GJ, Auchampach JA. Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc Res 1992;26:1011-6.
15. Toller W, Kersten J, Pagel P, et al. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 1999;91:1437-46.
16. ATP channels via multiple signaling pathways. Anesthesiology 2002;97:4-14.
17. Warltier D, Al-Wathiqui M, Kampine J, Schmelling W. Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 1988;69:552-65.
18. Kersten JR, Brayer AP, Pagel PS, et al. Perfusion of ischemic myocardium during anesthesia with sevoflurane. Anesthesiology 1994;81:995-1004.
19. Liu R, Ishibe Y, Ueda M. Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. Anesthesiology 2000;92:833-40.
20. Meissner A, Weber TP, Van Aken H, et al. Recovery from myocardial stunning is faster with desflurane compared with propofol in chronically instrumented dogs. Anesth Analg 2000;91:1333-8.
21. Piriou V, Chiari P, Lhuillier F, et al. Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium. Br J Anaesth 2002;89:486-91.
22. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004;100:707-21.
23. Zaugg M, Lucchinetti E, Uecker M, et al. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms. Br J Anaesth 2003;91:551-65.
24. Mathur S, Farhangkhgoee P, Karmazyn M. Cardioprotective effects of propofol and sevoflurane in ischemic and reperfused rat hearts: role of K(ATP) channels and interaction with the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Anesthesiology 1999;91:1349-60.
25. Mathur S, Karmazyn M. Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) in ischemic and reperfused rat hearts. Anesthesiology 1997;87:1460-9.
26. Kowalski C, Zahler S, Becker BF, et al. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology 1997;86:188-95.
27. Heindl B, Reichle FM, Zahler S, et al. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999;91:521-30.
28. Heindl B, Conzen PF, Becker BF. The volatile anesthetic sevoflurane mitigates cardiodepressive effects of platelets in reperfused hearts. Basic Res Cardiol 1999;94:102-11.
29. Hu G, Vasiliauskas T, Salem MR, et al. Neutrophils pretreated with volatile anesthetics lose ability to cause cardiac dysfunction. Anesthesiology 2003;98:712-8.
30. Riess ML, Camara AK, Chen Q, et al. Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am J Physiol Heart Circ Physiol 2002;283:H53-60.
31. Riess ML, Novalija E, Camara AK, et al. Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid. Anesthesiology 2003;98:387-95.
32. Kevin LG, Novalija E, Riess ML, et al. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003;96:949-55.
33. Novalija E, Varadarajan SG, Camara AK, et al. Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002;283:H44-52.
34. Novalija E, Kevin LG, Eells JT, et al. Anesthetic preconditioning improves adenosine triphosphate synthesis and reduces reactive oxygen species formation in mitochondria after ischemia by a redox dependent mechanism. Anesthesiology 2003;98:1155-63.
35. Mullenheim J, Ebel D, Frassdorf J, et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-40.
36. Tanaka K, Weihrauch D, Kehl F, et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 2002;97:1485-90.
37. Novalija E, Fujita S, Kampine JP, Stowe DF. Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. Anesthesiology 1999;91:701-12.
38. Kevin LG, Katz P, Camara AK, et al. Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology 2003;99:385-91.
39. 2+ responses in intact hearts. Am J Physiol Heart Circ Physiol 2001;281:H1508-23.
40. Mitsuhata H, Shimizu R, Yokoyama MM. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol 1995;17:529-34.
41. Tyther R, O'Brien J, Wang J, et al. Effect of sevoflurane on human neurrophil apoptosis. Eur J Anaesthesiol 2003;20:111-5.
42. de Klaver MJ, Manning L, Palmer LA, Rich GF. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. Anesthesiology 2002;97:24-32.
43. Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology 2004;100:540-6.
44. Plachinta RV, Hayes JK, Cerilli LA, Rich GF. Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats. Anesthesiology 2003;98:89-95.
45. Giraud O, Molliex S, Rolland C, et al. Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture. Anesthesiology 2003;98:74-81.
46. Hanley P, Ray J, Brandt U, Daut J. Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002;544.3:687-93.
47. ATP channel. Anesthesiology 2002;97:57-65.
48. Toller WG, Montgomery MW, Pagel PS, et al. Isoflurane-enhanced recovery of canine stunned myocardium: role for protein kinase C? Anesthesiology 1999;91:713-22.
49. ATP channel. Anesthesiology 2002;97:1198-208.
50. Pouzet B, Lecharny JB, Dehoux M, et al. Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 2002;73:843-8.
51. 2+ overload during ischemia in guinea pig intact hearts: reversal by 5-hydroxydecanoic acid. Anesth Analg 2002;95:1540-6.
52. 2+ loading in intact hearts. Anesthesiology 2002;96:125-33.
53. Takahata O, Ichihara K, Ogawa H. Effects of sevoflurane on ischaemic myocardium in dogs. Acta Anaesthesiol Scand 1995;39:449-56.
54. Kanaya N, Kobayashi I, Nakayama M, et al. ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart. Br J Anaesth 1995;74:563-8.
55. Richard V, Kaeffer N, Tron C, Thuillez C. Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 1994;89:1254-61.
56. Bouchard JF, Lamontagne D. Mechanisms of protection afforded by preconditioning to endothelial function against ischemic injury. Am J Physiol 1996;271:H1801-6.
57. Lynch C. Anesthetic preconditioning: not just for the heart. Anesthesiology 1999;91:606-8.
58. Crystal GJ, Zhou X, Gurevicius J, et al. Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology 2000;92:1103-13.
59. Crystal GJ, Gurevicius J, Salem MR, Zhou X. Role of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by halothane, isoflurane, and enflurane. Anesthesiology 1997;86:448-58.
60. Bollen BA, McKlveen RE, Stevenson JA. Halothane relaxes previously constricted human epicardial coronary artery segments more than isoflurane. Anesth Analg 1992;75:4-8.
61. ATP channel opening. Anesth Analg 2000;91:76-81.
62. Preckel B, Schlack W, Comfere T, et al. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998;81:905-12.
63. Schlack W, Preckel B, Stunneck D, Thamer V. Effects of halothane, enflurane, isoflurane, sevoflurane and desflurane on myocardial reperfusion injury in the isolated rat heart. Br J Anaesth 1998;81:913-9.
64. Obal D, Preckel B, Scharbatke H, et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001;87:905-11.
65. Obal D, Scharbatke J, Mullenheim J, et al. Myocardial protection by preconditioning with sevoflurane is further enhanced by sevoflurane administration during reperfusion [abstract]. Anesthesiology 2002;97:A-607.
66. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-7.
67. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 1995;91:37-45.
68. Ishihara M, Inoue I, Kawagoe T, et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001;38:1007-11.
69. Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994;90:700-5.
70. Laskey WK, Beach D. Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention. J Am Coll Cardiol 2003;42:998-1003.
71. Lambiase PD, Edwards RJ, Cusack MR, et al. Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. J Am Coll Cardiol 2003;41:1174-82.
72. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-7.
73. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997;77:314-8.
74. Wu ZK, Iivainen T, Pehkonen E, et al. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation 2002;106:3091-6.
75. Sergeev P, da Silva R, Lucchinetti E, et al. Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004;100:474-88.
76. Sommerschild H, Kirkeboen K. Preconditioning: endogenous defence mechanisms of the heart. Acta Anaesthesiol Scand 2002;46:123-37.
77. Belhomme D, Peynet J, Louzy M, et al. Evidence of preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999;100(suppl II):II-340-II4.
78. Penta de Peppo A, Polisca P, Tomai F, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999;68:112-8.
79. Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on troponin I release. G Ital Cardiol 1999;29:1007-14.
80. Haroun-Bizri S, Khoury SS, Chehab IR, et al. Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001;15:418-21.
81. Julier K, da Silva R, Varcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
82. De Hert S, ten Broecke P, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002;97:42-9.
83. De Hert S, Cromheecke S, ten Broecke P, et al. Effects of propofol, desflurane, and sevoflurane on recovery of myocardial function after coronary surgery in elderly high-risk patients. Anesthesiology 2003;99:314-23.
84. Van der Linden P, Daper A, Trenchant A, De Hert S. Cardioprotective effects of volatile anaesthetics in cardiac surgery. Anesthesiology 2003;99:516-7.
85. El Azab SR, Rosseel PM, De Lange JJ, et al. Effect of sevoflurane on the ex vivo secretion of TNF-alpha during and after coronary artery bypass surgery. Eur J Anaesthesiol 2003;20:380-4.
86. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-33.
87. Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989;70:179-88.
88. Tuman KJ, McCarthy RJ, Spiess BD, et al. Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 1989;70:189-98.
89. 1 receptors and adenosine triphosphate-sensitive potassium channels. Anesthesiology 2000;92:1692-701.
90. Eagle K, Berger P, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery update: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). American College of Cardiology, 2002. Available at: http://www.acc.org/clinical/guidelines/perio/ update/periupdate_index.htm.
91. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004;101:9-20.
92. Xiong L, Zheng Y, Wu M, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate- regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003;96:233-7.
93. Imai M, Kon S, Inaba H. Effects of halothane, isoflurane and sevoflurane on ischemia-reperfusion injury in the perfused liver of fasted rats. Acta Anaesthesiol Scand 1996;40:1242-8.